Tonix Pharmaceutics Holdings Inc. (TNXP) stock gains during current market. What’s driving it high?
Tonix Pharmaceuticals Holdings Inc. (TNXP) stock gains by 2.81% in the current market trading session. Tonix is a clinical-stage biopharmaceutical business dedicated on finding, licensing, purchasing, and developing small molecules and biologics to cure, prevent, and relieve human illness. Tonix’s portfolio is largely made up of pharmaceutical candidates for the central nervous system and immunology. […]
Tonix Pharmaceuticals Inc. (TNXP) stock soars during pre-market trading. Let’s find out why?
Tonix Pharmaceuticals Inc. (NASDAQ: TNXP) stock gained by 5.65% at the last close while the TNXP stock price rises by 3.82% in the pre-market trading session. Tonix is a clinical-stage pharmaceutical business dedicated on finding, licensing, purchasing, and developing small molecules and biologics to cure, prevent, and relieve human illness. Tonix’s portfolio is mostly made […]
What’s Driving Tonix Pharmaceuticals (TXNP) Stock Higher
Just before the start of the regular session today, Tonix Pharmaceuticals Holding Corp. (TNXP) stock has been trading premarket at a rise of 6.75% to $1.74. The clinical-stage biopharmaceutical company this morning announced the licensing of technology for treating Prader-Willi syndrome. Get the hottest stocks to trade every day before the market opens 100% free. […]
What is prompting this biotech stock (TNXP) higher in the pre-market session?
TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) is a clinical-stage biopharmaceutical company focused on the discovery, licensing, acquisition, and development of small molecules and biologics to treat and prevent diseases in humans and prevent suffering. TONIX PHARMACEUTICALS stock surged 26.49% to $1.170 in the pre-market session today. Get the hottest stocks to trade every day before […]
